Bausch Health Cos., Inc. (BHC.TO)
11.91
+0.15
(+1.28%)
CAD |
TSX |
Nov 13, 16:00
Bausch Health Cos. Net Income (Quarterly) : 624.37M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 624.37M |
| June 30, 2026 | 359.94M |
| March 31, 2026 | -1.963B |
| December 31, 2025 | -143.62M |
| September 30, 2025 | 249.26M |
| June 30, 2025 | 177.25M |
| March 31, 2025 | -123.40M |
| December 31, 2024 | 137.05M |
| September 30, 2024 | -125.49M |
| June 30, 2024 | -1.368M |
| March 31, 2024 | -103.84M |
| December 31, 2023 | -64.01M |
| September 30, 2023 | -512.36M |
| June 30, 2023 | 36.26M |
| March 31, 2023 | -282.68M |
| December 31, 2022 | -556.62M |
| September 30, 2022 | 526.37M |
| June 30, 2022 | -177.49M |
| March 31, 2022 | -83.60M |
| December 31, 2021 | 90.76M |
| September 30, 2021 | 240.67M |
| June 30, 2021 | -728.08M |
| March 31, 2021 | -768.61M |
| December 31, 2020 | -198.07M |
| September 30, 2020 | 93.28M |
| Date | Value |
|---|---|
| June 30, 2020 | -450.27M |
| March 31, 2020 | -204.45M |
| December 31, 2019 | -2.002B |
| September 30, 2019 | -63.39M |
| June 30, 2019 | -227.45M |
| March 31, 2019 | -63.81M |
| December 31, 2018 | -451.66M |
| September 30, 2018 | -458.77M |
| June 30, 2018 | -1.126B |
| March 31, 2018 | -3.262B |
| December 31, 2017 | 650.90M |
| September 30, 2017 | 1.629B |
| June 30, 2017 | -49.75M |
| March 31, 2017 | 832.45M |
| December 31, 2016 | -683.19M |
| September 30, 2016 | -1.590B |
| June 30, 2016 | -391.89M |
| March 31, 2016 | -512.28M |
| December 31, 2015 | -515.97M |
| September 30, 2015 | 67.60M |
| June 30, 2015 | -63.51M |
| March 31, 2015 | 122.23M |
| December 31, 2014 | 581.12M |
| September 30, 2014 | 300.83M |
| June 30, 2014 | 133.06M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| HLS Therapeutics, Inc. | -3.116M |
| Cipher Pharmaceuticals, Inc. | 15.25M |
| BioSyent, Inc. | 2.849M |
| Revive Therapeutics Ltd. | 0.0033M |
| Knight Therapeutics, Inc. | -2.68M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 4.117B |
| Total Expenses (Quarterly) | 3.507B |
| EPS Diluted (Quarterly) | 1.603 |
| Enterprise Value | 31.74B |
| Gross Profit Margin (Quarterly) | 67.29% |
| Profit Margin (Quarterly) | 15.16% |
| Earnings Yield | -26.11% |
| Operating Earnings Yield | 93.81% |
| Normalized Earnings Yield | 12.71 |